Back to top
more

OPKO Health (OPK)

(Delayed Data from NSDQ)

$1.26 USD

1.26
1,938,225

+0.04 (3.28%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $1.26 0.00 (0.00%) 5:42 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (86 out of 252)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Abiomed's (ABMD) Preliminary Q3 Results Cheer Investors

Abiomed (ABMD) raises its fiscal 2019 guidance. The company also expects to see strong contribution from its core Impella product line.

Here's Why Investors Should Hold Luminex (LMNX) Stock Now

Luminex (LMNX) gains from strength in the Aries platform. However, cutthroat competition in the life sciences industry is worrisome.

Here's Why Investors Should Hold DENTSPLY (XRAY) Stock Now

DENTSPLY (XRAY) gains from strength in CAD/CAM dental imaging platform. However, sluggishness in the European business is worrisome.

Luminex Buys MilliporeSigma's Flow Cytometry Unit for $75M

The recent buyout is likely to contribute $40-$50 million to Luminex's (LMNX) revenues in 2019.

Here's Why You Should Invest in PerkinElmer (PKI) Stock Now

Focus on emerging markets, improving margins and encouraging guidance provide PerkinElmer (PKI) a competitive edge in the MedTech space.

Here's Why You Should Invest in Wright Medical (WMGI) Now

A bullish outlook and a wide array of products make Wright Medical (WMGI) a promising investment pick.

Ecolab Inks Deal With Clearway for Renewable Power Project

Ecolab's (ECL) virtual power purchase agreement with Clearway is part of a broader trend among corporate buyers. This will cover the company???s annual domestic energy use completely.

Here's Why Investors Should Retain CONMED (CNMD) Stock Now

CONMED's (CNMD) steady focus on innovation is indicative of brighter prospects ahead. The company faces cutthroat competition in the niche space.

Becton, Dickinson's MAX Enteric Viral Panel Cleared by FDA

Becton, Dickinson's (BDX) Diagnostic Systems portfolio lends it a competitive edge.

Here's Why You Should Buy Intuitive Surgical (ISRG) Now

A solid outlook for 2018 and strength in robotics make Intuitive Surgical (ISRG) a promising investment pick.

Varian Medical's (VAR) Halcyon Excluded From Trade Tariffs

Recent trade war-related talks are likely to favor Varian Medical (VAR) in the long run.

Here's Why You Should Hold Becton, Dickinson (BDX) Stock Now

Plethora of developments for Becton, Dickinson (BDX); headwinds apprehended in fiscal 2019.

Integra Rides on Global Prospects, Hurt by Escalating Costs

Integra LifeSciences (IART) aims at investment openings in the Asian market for a faster business boost than in the United States and also to flourish specific parts of its international businesses.

Quest Diagnostics (DGX) Divests India Business to Strand

Quest Diagnostics (DGX) sees lucrative prospects in the U.S. diagnostic testing market.

Cala Health Picks Medidata Cloud for Observational Study

Medidata's (MDSO) Cloud platform sees a slew of developments in recent times.

Inogen Gains From Commercial Launch of Wireless Connect

Inogen's (INGN) expanding product portfolio lends it a competitive edge in the respiratory care devices market.

Here's Why You Should Hold HealthEquity (HQY) Stock for Now

HealthEquity's (HQY) fiscal third-quarter results hold promise while competition is stiff.

Baxter Stock up on Launch of Disposable Curved Applicator

Baxter's (BAX) wide array of surgical products see lucrative market prospects.

Here's Why You Should Hold Cooper Companies (COO) Stock Now

Cooper Companies' (COO) strong CVI segment favors the stock while a soft Fertility unit raises concern.

CONMED's Buffalo Filter Buyout Likely to be Accretive in 2020

CONMED's (CNMD) comprehensive surgical smoke evacuation portfolio lends it a competitive edge in the industry.

Varian Medical's Eclipse Picked by Paul Scherrer Institute

Varian Medical's (VAR) latest developments fortify its foothold in the global cancer therapeutics market.

Here's Why You Should Hold Baxter International (BAX) Now

Baxter's (BAX) recent string of developments boost the stock while segmental softness is a concern.

Varian Medical ProBeam-Equipped Emory Center Opens in Georgia

Varian Medical's (VAR) flagship ProBeam system has lucrative prospects.

Baxter & EFCNI Collaborate to Improve Care for Preterm Born

Baxter's (BAX) latest move is likely to increase the use of Baxter's Numeta G13E triple-chamber PN product.

Here's Why You Should Invest in athenahealth (ATHN) Now

A strong guidance and focus on big data-based health records system make athenahealth (ATHN) a solid investment pick.